Listar INIBIC-ICATC - Artigos por título
Mostrando ítems 55-74 de 174
-
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
(John Wiley & Sons, 2024-03-04)[Abstract] Aims: To evaluate the effect of long-term tafamidis treatment on health-related quality of life (HRQoL) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) enrolled in the Tafamidis in Transthyretin ... -
Effect of β-blockers on 1-year survival and hospitalizations in patients with heart failure and atrial fibrillation: results from ESC-HF pilot and ESC-HF long-term registry
(Medycyna Praktyczna, 2018-10-10)[Abstract] Introduction The positive effect of β-blocker therapy in patients with heart failure (HF) and atrial fibrillation (AF) has been questioned. Objectives We aimed to assess the effect of β-blockers and heart rate ... -
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION‐HEART multicentre randomised trial
(Wiley, 2018)[Abstract] Aims. The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group, placebo‐controlled trial evaluating the efficacy and safety of intravenous administration of intermittent doses of levosimendan ... -
Empleo del balón de contrapulsación intraaórtico como puente al trasplante cardiaco en España: resultados del estudio ASIS-TC
(Elsevier, 2018)[Resumen] Introducción y objetivos. En España, el balón de contrapulsación intraaórtico (BCIA) se ha usado frecuentemente como puente al trasplante cardiaco (TxC) urgente. El propósito es analizar los resultados de esta ... -
Epidemiological study of tricuspid regurgitation after cardiac transplantation: does it influence survival?
(Frontiers, 2022-03-21)[Abstract] Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. ... -
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry
(Wiley, 2017-04-06)[Abstract] AIMS: The objectives of the present study were to describe epidemiology and outcomes in ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and to identify predictors ... -
Estado serológico frente a Toxoplasma gondii en receptores de trasplante cardiaco: ¿un factor pronóstico independiente?
(Elsevier, 2016-08-31)[Resumen] Introducción y objetivos. Analizar la influencia pronóstica del estado serológico frente a Toxoplasma gondii en receptores de trasplante cardiaco (TC). Métodos. Se realizó un estudio retrospectivo unicéntrico ... -
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions
(Wiley, 2016-06-20)[Abstract] AIMS: The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart failure (HF) ... -
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study
(Elsevier, 2017)[Abstract] BACKGROUND: New biomarkers are necessary to improve detection of the risk of infection in heart transplantation. We performed a multicenter study to evaluate humoral immunity profiles that could better enable ... -
Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology
(Wiley, 2018-11-26)[Abstract] Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate early physical activity and to facilitate recovery and improve health behaviours. ET has also been proposed ... -
Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure
(Ivyspring, 2017-07-20)[Abstract] Epicardial adipose tissue has been proposed to participate in the pathogenesis of heart failure. The aim of our study was to assess the expression of thermogenic genes (Uncoupling protein 1 (UCP1), peroxisome ... -
Expression of sterol regulatory element-binding proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study
(Ivyspring, 2017-02-23)[Abstract] Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in ... -
Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling
(American Heart Association, 2021-11-22)[Abstract] Background: Remodeling of the extracellular matrix (ECM) is a hallmark of heart failure (HF). Our previous analysis of the secretome of murine cardiac fibroblasts returned ADAMTS5 (a disintegrin and metalloproteinase ... -
Fifteen-year differences in indications for cardiac resynchronization therapy in international guidelines—insights from the heart failure registries of the European Society of Cardiology
(MDPI, 2022-06-06)[Abstract] Cardiac resynchronization therapy (CRT) applied to selected patients with heart failure (HF) improves their prognosis. In recent years, eligibility criteria for CRT have regularly changed. This study aimed to ... -
Furosemida subcutánea mediante infusor elastomérico en pacientes ambulatorios con insuficiencia cardiaca: experiencia inicial
(Asociación Española de Enfermería en Cardiología (AEEC), 2024-02-06)[Resumen] Introducción. Una causa frecuente de hospitalización en pacientes con insuficiencia cardiaca es congestión refractaria a diuréticos orales y se trata con furosemida intravenosa. La administración de furosemida ... -
Guidance on the Management of Left Ventricular Assist Device (LVAD) Supported Patients for the Non-LVAD Specialist Healthcare Provider: Executive Summary
(Wiley, 2021-08-18)[Abstract] The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of patients on the device ... -
Health‐related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross‐sectional study
(Wiley, 2015-06-15)[Abstract] A multicenter cross-sectional study was conducted to determine the current heart transplant (HTx) outcomes in Spain. Clinical and functional status, health-related quality of life (HRQoL), social support, and ... -
Heart Failure Association of the European Society of Cardiology Position Paper on the Management of Left Ventricular Assist Device-Supported Patients for the Non-left Ventricular Assist Device Specialist Healthcare Provider: Part 2: At the Emergency Department
(Wiley, 2021-09-14)[Abstract] The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD-supported patients and the probability of those patients ... -
Heart rate control and its predictors in patients with heart failure and sinus rhythm: data from the European Society of Cardiology Long-Term Registry
(Via Medica, 2022-08-17)[Abstract] Background: Higher resting heart rate (HR) in patients with heart failure (HF) and sinus rhythm (SR) is associated with increased mortality. In patients hospitalized for HF, the aim herein, was to assess the ...